CVS241115C77500
- 0.13
- 0.000.00%
CVS Health Newsroom
RBC Capital lowered CVS Health's target price to $58.
RBC Capital: lowered the target price for CVS Health from $68 to $58, maintaining an "outperform large cap" rating. (Gelonghui)
Large Pension Doubled Palantir Stake, Bought Up Intel and CVS Stock -- Barrons.com
CVS Health (NYSE:CVS) Sheds US$3.0b, Company Earnings and Investor Returns Have Been Trending Downwards for Past Three Years
CVS Health's 2025 'Less Certain' Following 2024 Guidance Withdrawal, Changes in Leadership, RBC Capital Says
Analyst Expectations For CVS Health's Future
CVS Health Is Maintained at Outperform by RBC Capital
CVS Health Analyst Ratings
RBC Capital Maintains CVS Health(CVS.US) With Buy Rating, Cuts Target Price to $58
RBC Capital Reaffirms Their Buy Rating on CVS Health (CVS)
Express News | CVS Health Corp : RBC Cuts Target Price to $58 From $68
Third Point Hedge Fund Buys Tesla, Dumps Micron
Third Point 13F Shows Added Stake In Brookfield Corp With 4,725,000 Shares; Ferguson Enterprises With 965,000 Shares; Flutter Entertainment With 510,000 Shares; LPL Financial Holdings With 485,000 Shares; Carpenter Technology With 660,000 Shares;...
Dan Loeb's Third Point Enters Tesla, CVS, Exits Uber, Verizon, Among Top Q3 Trades
Medicare to Adjust Disputed Star Rating Measure: Bloomberg News
Stocks on Sale: CVS Health, Moderna, and Albemarle
10 Dividend Stocks That Yield 3% or More
10 Health Care Stocks With Whale Alerts In Today's Session
Myriad Genetics Says Fetal Gender Test Available at Over 8,000 Stores in US
Is Trending Stock CVS Health Corporation (CVS) a Buy Now?
J.P. Morgan Maintains CVS Health(CVS.US) With Buy Rating, Cuts Target Price to $80